NOTCH3, a crucial target of miR-491-5p/miR-875-5p, promotes gastric carcinogenesis by upregulating PHLDB2 expression and activating Akt pathway.

Abstract

Aberrant Notch activation has been implicated in multiple malignancies and the identification of NOTCH receptors and related pathways is critical for targeted therapy. In this study, we aim to delineate the most prominent dysregulated NOTCH receptor and comprehensively reveal its deregulation in gastric cancer (GC). In the four Notch members, NOTCH3 was found uniformly upregulated and associated with poor clinical outcomes in multiple GC datasets. siRNA-mediated NOTCH3 knockdown demonstrated antitumor effects by suppressing cell proliferation, inhibiting monolayer formation, and impairing cell invasion abilities. Its depletion also induced early and late apoptosis. NOTCH3 was confirmed to be a direct target of two tumor suppressor microRNAs (miRNAs), namely miR-491-5p and miR-875-5p. The activation of NOTCH3 is partly due to the silence of these two miRNAs. Through RNA-seq profiling and functional validation, PHLDB2 was identified as a potent functional downstream modulator for NOTCH3 in gastric carcinogenesis. PHLDB2 expression demonstrated a positive correlation with NOTCH3, but was negatively correlated with miR-491-5p. Akt-mTOR was revealed as the downstream signaling of PHLDB2. The NOTCH3-PHLDB2-Akt co-activation was found in 33.7% GC patients and the activation of this axis predicted poor clinical outcome. GC cells treated with siNOTCH3, siPHLDB2, miR-491-5p, miR-875-5p, were more sensitive to Cisplatin and 5-FU. Taken together, the NOTCH3-PHLDB2-Akt cascade plays oncogenic role in gastric carcinogenesis and serves as a therapeutic target. Our study provided insights into Notch-mediated underlying molecular mechanisms and implied translational potential.

• Authors: Wei Kang, Jinglin Zhang, Tingting Huang, Yuhang Zhou, Chi Chun Wong, Ronald C K Chan, Yujuan Dong, Feng Wu, Bin Zhang, William K K Wu, Michael W Y Chan, Alfred S L Cheng, Jun Yu, Nathalie Wong, Kwok Wai Lo, Ka Fai To
• Journal: Oncogene (Oncogene) Vol. 40 Issue 9 Pg. 1578-1594 (03 2021) ISSN: 1476-5594 [Electronic] England
• PMID: 33452458 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Carrier Proteins
• MIRN-875 microRNA, human
• MIRN491 microRNA, human
• MicroRNAs
• NOTCH3 protein, human
• PHLDB2 protein, human
• RNA, Small Interfering
• Receptor, Notch3
• MTOR protein, human
• Oncogene Protein v-akt
• TOR Serine-Threonine Kinases
• Cisplatin
• Fluorouracil

Topics

• Apoptosis (genetics)
• Carcinogenesis (genetics)
• Carrier Proteins (genetics)
• Cell Line, Tumor
• Cell Movement (genetics)
• Cell Proliferation (genetics)
• Cisplatin (pharmacology)
• Drug Resistance, Neoplasm (genetics)
• Fluorouracil (pharmacology)
• Gene Expression Regulation, Neoplastic (drug effects)
• Humans
• MicroRNAs (genetics)
• Oncogene Protein v-akt (genetics)
• RNA, Small Interfering (genetics)
• Receptor, Notch3 (genetics)
• Stomach Neoplasms (genetics, pathology)
• TOR Serine-Threonine Kinases (genetics)